Tech Company Financing Transactions
Oncoceutics Funding Round
On 9/30/2014, Oncoceutics raised funding from Spring Mountain Capital.
Transaction Overview
Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Spring Mountain Capital (Lead Investor) (Raymond Wong)
Proceeds Purpose
The company intends to use the proceeds, in conjunction with non-dilutive grant awards, public-private partnerships and academic alliances, to accelerate the early clinical development (Phase I and Phase II) of its lead product, ONC201, a small molecule that possesses anti-tumor activity in a number of different types of human cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3675 Market St. 200
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Undisclosed
Website
Email Address
Overview
Oncoceutics, Inc. is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The company's leadership team represents a group of drug development executives with unparalleled success in the industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lee Schalop
VP - Bus. Development
Martin Stogniew
VP - R & D
Joshua Allen
Browse more venture capital transactions:
Prev: 9/30/2014: SegONE venture capital transaction
Next: 9/30/2014: Parcel Pending venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs